CardioVascular BioTherapeutics Cash Flow Statement
View: Annual
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Net Operating Cash Flow | (13.3) | (17.6) | (10.7) |
| Net Investing Cash Flow | 0.1 | (0.9) | (0.2) |
| Net Financing Cash Flow | 5.1 | 18.4 | 15.1 |
| Net Change in Cash | (8.2) | (0.2) | 4.1 |
| Depreciation & Amortization | 7.1 | 4.1 | 1.4 |
| Capital Expenditures | (0.1) | (0.8) | (0.2) |
| Cash Dividends Paid | -- | -- | -- |
This data is provided as per license from EDGAR Online
